Krystal Biotech Inc (KRYS) — Free Cash Flow Generation Index

Latest as of March 2026: 0.91x

Krystal Biotech Inc (KRYS) has a Free Cash Flow Generation Index of 0.91x as of March 2026. Free cash flow of $73.23 Million represents 1% of operating cash flow ($80.38 Million). Read Krystal Biotech Inc (KRYS) financial obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

0.91x
Free Cash Flow / Operating CF

Free Cash Flow

$73.23 Million
USD

Operating Cash Flow

$80.38 Million
USD

Capital Expenditures

$7.15 Million
USD

Krystal Biotech Inc Free Cash Flow Generation Index (2024–2025)

Historical FCF Generation Index trend for Krystal Biotech Inc across 2 annual periods. Explore KRYS capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Krystal Biotech Inc (2024–2025)

Year-by-year Free Cash Flow Generation Index for Krystal Biotech Inc. For the full company profile including market capitalisation, see Krystal Biotech Inc market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.94x $188.91 Million $200.87 Million $11.95 Million ▼ -2.6%
2024 0.97x $119.18 Million $123.42 Million $4.24 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).